Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer

BACKGROUND: The role of postoperative radiotherapy (PORT) in patients with clinical stage III-N2 (cIII-N2) non-small cell lung cancer (NSCLC) treated with induction chemotherapy and surgical resection with persistent ypN2 disease is not well-established. METHODS: We retrospectively reviewed a prospe...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Thorac Surg
Prif Awduron: Brandt, Whitney S., Yan, Wanpu, Leeman, Jonathan E., Tan, Kay See, Park, Bernard J., Adusumilli, Prasad S., Bott, Matthew J., Molena, Daniela, Isbell, James, Chaft, Jamie, Rimner, Andreas, Jones, David R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2018
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136648/
https://ncbi.nlm.nih.gov/pubmed/29807005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2018.04.064
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg